ESRRA and oral cavity squamous cell carcinoma: These include synergism observed between rapamycin and inhibition of ERRα during lipid metabolic activities in fatty liver (Chaveroux et al., 2013), T cell activation (Michalek et al., 2011), and following induction of tumorigenesis in oral squamous cell carcinoma cells (Gan et al., 2017).